Home
Transgene Biotek Ltd Quarterly Result
Transgene Biotek Ltd
NSE: TRANSGENEBIOTEK
Net Profit - Last Quarter
Key Highlights
- The revenue of Transgene Biotek Ltd for the Sep '24 is ₹ 0.1 crore as compare to the Jun '24 revenue of ₹ 0.7 crore. This represent the decline of -85.71428%.
- The ebitda of Transgene Biotek Ltd for the Sep '24 is ₹ -0.03 crore as compare to the Jun '24 ebitda of ₹ 0.24 crore. This represent the decline of -112%.
- The net profit of Transgene Biotek Ltd for the Sep '24 is ₹ -0.07 crore as compare to the Jun '24 net profit of ₹ 0.2 crore. This represent the decline of -135%.
Results Analysis
Market Price of Transgene Biotek Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
|---|
| 07 Jan 2025 | 4.76 | 4.76 | 5.12 | 4.76 |
| 06 Jan 2025 | 5.01 | 5.01 | 5.01 | 5.01 |
| 03 Jan 2025 | 5.27 | 5.27 | 5.5 | 5.27 |
| 02 Jan 2025 | 5.54 | 5.66 | 5.96 | 5.54 |
| 01 Jan 2025 | 6.15 | 6.8 | 6.95 | 6.15 |
| 31 Dec 2024 | 6.83 | 7.55 | 7.55 | 6.7 |
| 30 Dec 2024 | 7.28 | 7.71 | 7.71 | 7.2 |
| 27 Dec 2024 | 7.51 | 7.73 | 7.9 | 7.12 |
| 26 Dec 2024 | 7.24 | 7.08 | 7.33 | 6.86 |
| 24 Dec 2024 | 6.94 | 7.31 | 7.6 | 6.67 |
| Date |  Price (₹) |
|---|---|
| 07 Jan 2025 | 4.76 |
| 06 Jan 2025 | 5.01 |
| 03 Jan 2025 | 5.27 |
| 02 Jan 2025 | 5.54 |
| 01 Jan 2025 | 6.15 |
| 31 Dec 2024 | 6.83 |
| 30 Dec 2024 | 7.28 |
| 27 Dec 2024 | 7.51 |
| 26 Dec 2024 | 7.24 |
| 24 Dec 2024 | 6.94 |
Historical Revenue of Transgene Biotek Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Transgene Biotek Ltd
Historical EBITDA of Transgene Biotek Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Transgene Biotek Ltd
Historical Net Profit of Transgene Biotek Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Transgene Biotek Ltd
Transgene Biotek Ltd News Hub
Transgene Biotek reports consolidated net profit of Rs 0.20 crore in the June 2024 quarter
Net profit of Transgene Biotek reported to Rs 0.20 crore in the quarter ended June 2024 as against n
Read more
2024-08-12 00:00:00
Transgene Biotek to announce Quarterly Result
Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 November 2024 Po
Read more
2024-11-05 00:00:00
Transgene Biotek reports consolidated net loss of Rs 0.07 crore in the September 2024 quarter
Net Loss of Transgene Biotek reported to Rs 0.07 crore in the quarter ended September 2024 as agains
Read more
2024-11-12 00:00:00
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
FAQs for Quarterly Results of Transgene Biotek Ltd
What key financial metrics are included in Transgene Biotek Ltd's quarterly results?
When does Transgene Biotek Ltd announce its quarterly results?
How does Transgene Biotek Ltd's quarterly performance impact its stock price?
What is the impact of Transgene Biotek Ltd's quarterly results on dividends?
Are there any special announcements usually made during Transgene Biotek Ltd's quarterly results?
